Release Date: October 31, 2024
Expiration Date: October 31, 2025
Activity Overview
Tardive dyskinesia (TD), a neurological disorder characterized by involuntary movement, is commonly associated with exposure to antipsychotic medication. TD can have significant impacts on a patient’s quality of life due to functional challenges and social stigmatization. Comprehensive assessment of TD burden and severity is needed to guide treatment decisions and optimize outcomes.
This Community Practice Connection™ program provides an in-depth review of some of the key highlights at the Southern California Psychiatry Conference, held in September 2024. This unique and engaging multi-media activity is ideal for the community-based health care professional and focuses on the practical aspects of diagnosis and treatment of TD. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Target Audience
This educational curriculum is directed toward psychiatrists, nurse practitioners, neuropsychiatrists, neurologists, primary care practitioners, physician assistants, registered nurses, pharmacists, and other health care providers involved in the management of patients with TD.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the impact of tardive dyskinesia on patient quality of life
- Assess clinical trial results for therapies used in the management of tardive dyskinesia
- Integrate individualized treatment strategies for patients with tardive dyskinesia
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
